Browsing: Pharma

It was just nine months ago that Idolsia announced a CEO change, appointing Srishti Gupta,…

Eli Lilly recorded sales of $408 million in the first full year in the U.S.…

With Kerendia’s new Phase 3 victory, Bayer is one step closer to bringing this powerful…

Pharmacologists, drug development executives, and regulatory affairs professionals confront accelerating pharma trends in 2026 that reshape drug discovery, biopharma manufacturing, clinical pipelines, and FDA approvals. Discover key insights to stay ahead.

Pfizer CEO Dr. Albert Bourla has yet to surpass the $33 million he earned in…

GSK has secured FDA expansion of its respiratory syncytial virus vaccine Aleksby for adults aged…

Pharma trends 2026 bring surging R&D costs, regulatory volatility, and tech disruptions, but AI innovations, decentralized trials, and promising clinical pipelines offer key opportunities for drug developers.

From a 17-year development cycle to commercial launch, production has always been in Eztugo’s DNA.…

This week’s episode of “The Topline” takes a deep dive into the biopharmaceutical industry’s fourth…

The FDA has rejected Hyloris Pharmaceuticals’ antiviral drug valacyclovir, an oral suspension for infections caused…